Hemoglobina reticulocitaria: un nuevo parámetro del hemograma de gran valor en el diagnóstico y manejo de la eritropoyesis deficiente en hierro

  • Germán Campuzano-Maya Laboratorio Clínico Hematológico
  • Natalia M. Guevara-Arismendy Hospital San Vicente Fundación
Palabras clave: hemoglobina reticulocitaria, hemograma tipo VI, eritropoyesis deficiente en hierro, deficiencia absoluta de hierro, deficiencia funcional de hierro, secuestro de hierro.

Resumen

La incorporación de los autoanalizador de hematología al laboratorio clínico no solo mejoró la calidad de los resultados de los parámetros convencionales del hemograma sino que ha permitido, especialmente con aquellos de última generación, introducir nuevos parámetros de gran utilidad clínica. Uno de los nuevos parámetros es la hemoglobina reticulocitaria, la cual se vislumbra como una potente herramienta en el diagnóstico y el manejo de la eritropoyesis deficiente en hierro en sus diferentes manifestaciones, en particular la deficiencia absoluta de hierro, la deficiencia funcional de hierro y el secuestro del hierro. La hemoglobina reticulocitaria en todos los casos en donde hay eritropoyesis deficiente en hierro es el primer parámetro detectable en el hemograma y, a su vez, es el primero que se normaliza cuando la terapia administrada ha sido la adecuada; además, ha demostrado ser costo eficiente, sobre todo por ser un parámetro del hemograma más que una prueba adicional. El único problema, hasta el momento, es que solo está disponible en algunos autoanalizadores de hematología como los de las compañías Siemens y Sysmex, en sus modelos de cuarta generación, también conocidos como hemograma tipo VI o hemograma ampliado o extendido. Con el presente módulo se pretende presentar este nuevo parámetro que la comunidad médica debe incorporar como propio y los laboratorios clínicos deberían estar preparados para incorporarlo a sus portafolios de servicios, como una nueva herramienta complementaria en la prevención, la detección y el manejo de la eritropoyesis deficiente en hierro en sus diversas manifestaciones.

 

Descargas

La descarga de datos todavía no está disponible.

Biografía del autor/a

Germán Campuzano-Maya, Laboratorio Clínico Hematológico

Médico, especialista en Hematología y Patología Clínica. Docente Ad Honorem, Facultad de Medicina, Universidad de Antioquia. Coordinador Grupo de Investigación en Patología Clínica. Médico Director, Laboratorio Clínico Hematológico. Medellín, Colombia.

Natalia M. Guevara-Arismendy, Hospital San Vicente Fundación

Microbióloga y Bioanalista, MSc en Microbiología y Bioanálisis, énfasis Hematología. Bacterióloga, Hospital San Vicente Fundación. Medellín, Colombia.

 

Referencias bibliográficas

Gulati GL, Hyun BH. The automated CBC. A current perspective. Hematol Oncol Clin North Am 1994; 8: 593-603.

https://doi.org/10.1016/S0889-8588(18)30148-5

Perkins SL. Examination of the blood and bone marrow (actualizar con nueva versión). En: Greer JP, Foerster J, Lukens JN, Rodgers GM, Paraskevas F, Glader B, eds. Wintrobe's clinical hematology (ed 11th Edition). Philadelphia, PA, USA: Lipincott Williams & Wilkins; 2004: 1-25.

Sociedad Colombiana de Patología Clínica. Manual de Codificación, Nomenclatura, Nivelación y Valores de Exámenes de laboratorio Clínico. Medellín, Colombia: Edimeco S.A.; 2015.

Davis BH, Bigelow NC. Automated reticulocyte analysis. Clinical practice and associated new parameters. Hematol Oncol Clin North Am 1994; 8: 617-630.

https://doi.org/10.1016/S0889-8588(18)30150-3

Briggs C, Harrison P, Grant D, Staves J, MacHin SJ. New quantitative parameters on a recently introduced automated blood cell counter--the XE 2100. Clin Lab Haematol 2000; 22: 345-350.

https://doi.org/10.1046/j.1365-2257.2000.00330.x

Briggs C. Quality counts: new parameters in blood cell counting. Int J Lab Hematol 2009; 31: 277-297.

https://doi.org/10.1111/j.1751-553X.2009.01160.x

Urrechaga E, Borque L, Escanero JF. Potential utility of the new Sysmex XE 5000 red blood cell extended parameters in the study of disorders of iron metabolism. Clin Chem Lab Med 2009; 47: 1411-1416.

https://doi.org/10.1515/CCLM.2009.301

Sehgal KK, Tina D, Choksey U, Dalal RJ, Shanaz KJ. Reference range evaluation of complete blood count parameters with emphasis on newer research parameters on the complete blood count analyzer Sysmex XE-2100. Indian J Pathol Microbiol 2013; 56: 120-124.

https://doi.org/10.4103/0377-4929.118698

Arneth BM, Menschikowki M. Technology and New Fluorescence Flow Cytometry Parameters in Hematological Analyzers. J Clin Lab Anal 2014.

https://doi.org/10.1002/jcla.21747

Voss SC, Varamenti E, Elzain Elgingo M, Bourdon PC. New parameters and reference values for monitoring iron status in Middle Eastern adolescent male athletes. J Sports Med Phys Fitness 2014; 54: 179-185.

Brisou G, Manzoni D, Dalle S, Felman P, Morel D, Boubaya M, et al. Alarms and parameters generated by hematology analyzer: new tools to predict and quantify circulating Sezary cells. J Clin Lab Anal 2015; 29: 153-161.

https://doi.org/10.1002/jcla.21744

Goodnough LT, Nemeth E. Iron deficiency and related disorders. En: Greer JP, Arber DA, Glader B, List AF, Means RT, Paraskevas F, et al., eds. Wintrobe's clinical hematology (ed 13th Edition). Philadelphia, PA, USA: Wolters Kluwer. Lippincott Williams & Wilkins; 2014: 617-642.

Geissler C, Singh M. Iron, meat and health. Nutrients 2011; 3: 283-316.

https://doi.org/10.3390/nu3030283

Theil E, Raymond K. Transition-metal storage, transport, and biomineralization. En: Bertini I, Gray HB, Lippard SJ, Valentine JS, eds. Bioinorganic chemistry Mill Valley, CA: University Science Books; 1994: 611.

Hentze MW, Muckenthaler MU, Andrews NC. Balancing acts: molecular control of mammalian iron metabolism. Cell 2004; 117: 285-297.

https://doi.org/10.1016/S0092-8674(04)00343-5

Darshan D, Frazer DM, Anderson GJ. Molecular basis of iron-loading disorders. Expert Rev Mol Med 2010; 12: e36.

https://doi.org/10.1017/S1462399410001687

Ganz T. Hepcidin and iron regulation, 10 years later. Blood 2011; 117: 4425-4433.

https://doi.org/10.1182/blood-2011-01-258467

Rouault TA. Iron metabolism in the CNS: implications for neurodegenerative diseases. Nat Rev Neurosci 2013; 14: 551-564.

https://doi.org/10.1038/nrn3453

Papanikolaou G, Pantopoulos K. Iron metabolism and toxicity. Toxicol Appl Pharmacol 2005; 202: 199-211.

https://doi.org/10.1016/j.taap.2004.06.021

Food and Nutrition Board, Institute of Medicine. Dietary reference intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. Washington, DC: National Academy Press; 2002: 290-393.

Ganz T. Molecular control of iron transport. J Am Soc Nephrol 2007; 18: 394-400.

https://doi.org/10.1681/ASN.2006070802

Fleming RE, Bacon BR. Orchestration of iron homeostasis. N Engl J Med 2005; 352: 1741-1744.

https://doi.org/10.1056/NEJMp048363

Arezes J, Nemeth E. Hepcidin and iron disorders: new biology and clinical approaches. Int J Lab Hematol 2015; 37 Suppl 1: 92-98.

https://doi.org/10.1111/ijlh.12358

Camaschella C. Iron and hepcidin: a story of recycling and balance. Hematology Am Soc Hematol Educ Program 2013; 2013: 1-8.

https://doi.org/10.1182/asheducation-2013.1.1

Chifman J, Laubenbacher R, Torti SV. A systems biology approach to iron metabolism. Adv Exp Med Biol 2014; 844: 201-225.

https://doi.org/10.1007/978-1-4939-2095-2_10

Goodnough LT. Iron deficiency syndromes and iron-restricted erythropoiesis (CME). Transfusion 2012; 52: 1584-1592.

https://doi.org/10.1111/j.1537-2995.2011.03495.x

Pippard MJ. Iron deficiency anemia, anemia of chronic disorders and iron overload. En: Porwit A, McCullough J, Erber WN, eds. Blood and Bone Marrow Pathology (ed 2da). Edimburgo, Escocia: Churchill Livingstone; 2011: 173-195.

https://doi.org/10.1016/B978-0-7020-3147-2.00011-0

Milman N. Anemia--still a major health problem in many parts of the world! Ann Hematol 2011; 90: 369-377.

https://doi.org/10.1007/s00277-010-1144-5

WHO/UNICEF/UNU. Iron deficiency anemia assessment, prevention, and control. Geneva: World Health Organization; 2001.

Zimmermann MB, Hurrell RF. Nutritional iron deficiency. Lancet 2007; 370: 511-520.

https://doi.org/10.1016/S0140-6736(07)61235-5

Organización Mundial de la Salud, Centros para el Control y la Prevención de Enfermedades (CDC). Worldwide prevalence of anaemia 1993-2005: WHO Global Database on Anaemia. In: de Benoist B, McLean E, Egli I, Cogswell M eds. Ginebra, Suiza: WHO Press; 2009.

República de Colombia, Ministerio de la Protección Social, Instituto Colombiano de Bienestar Familiar, Instituto Nacional de Salud, Profamilia. Encuesta Nacional de la Situación Nutricional en Colombia 2010-ENSIN. Bogotá D.C., Colombia. 2011. Disponible: http://www.icbf.gov.co/portal/page/portal/PortalICBF/Bienestar/ENSIN1/ENSIN2010/LibroENSIN2010.pdf. Consultado: feb 2015.

Adamson JW. Ferropenia y otras anemias hipoproliferativas. En: Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL, Loscalzo J, eds. Harrison Principios de Medicina Interna (ed 18a). México, D. F.: McGraw-Hill Interamericana Editores; 2012: 844-851.

Heinrich HC. Iron deficiency without anemia. Lancet 1968; 2: 460.

https://doi.org/10.1016/S0140-6736(68)90506-0

Beutler E, Hoffbrand AV, Cook JD. Iron deficiency and overload. Hematology Am Soc Hematol Educ Program 2003: 40-61.

https://doi.org/10.1182/asheducation-2003.1.40

Camaschella C. Iron-deficiency anemia. N Engl J Med 2015; 372: 1832-1843.

https://doi.org/10.1056/NEJMra1401038

Brittenham GM. Disorders of iron homeostasis: iron deficiency and overload. En: Hoffman R, Furie B, Benz EJ, McGlave P, Silberstein LE, Shattil SJ, eds. Hematology: Basic Principles and Practice (ed 5ta). Filadelfia, Estados Unidos: Churchill Livingstone; 2009: 453-468.

Worwood M. Indicators of the iron status of populations: ferritin. In: Organización Mundial de la Salud, Centros para el Control y la Prevención de Enfermedades (CDC) eds. Assessing the iron status of populations (ed 2da). Ginebra, Suiza: WHO Press; 2007.

Cook JD. The measurement of serum transferrin receptor. Am J Med Sci 1999; 318: 269-276.

https://doi.org/10.1016/S0002-9629(15)40630-5

Worwood M, May A. Iron deficiency anaemia and iron overload. En: Bain BJ, Bates I, Laffan MA, Lewis SM, eds. Dacie and Lewis Practical Haematology (ed 11a). Filadelfia, Estados Unidos: Churchill Livingstone; 2011: 175-200.

https://doi.org/10.1016/B978-0-7020-3408-4.00009-6

Koller ME, Romslo I, Finne PH, Brockmeier F, Tyssebotn I. The diagnosis of iron deficiency by erythrocyte protoporphyrin and serum ferritin analyses. Acta Paediatr Scand 1978; 67: 361-366.

https://doi.org/10.1111/j.1651-2227.1978.tb16335.x

Labbe RF, Vreman HJ, Stevenson DK. Zinc protoporphyrin: A metabolite with a mission. Clin Chem 1999; 45: 2060-2072.

Uchida T, Kawati Y. Pagophagia in iron deficiency anemia. Rinsho Ketsueki 2014; 55: 436-439.

Osman YM, Wali YA, Osman OM. Craving for ice and iron-deficiency anemia: a case series from Oman. Pediatr Hematol Oncol 2005; 22: 127-131.

https://doi.org/10.1080/08880010590896486

Van Neste DJ, Rushton DH. Hair problems in women. Clin Dermatol 1997; 15: 113-125.

https://doi.org/10.1016/S0738-081X(96)00114-9

Rushton DH. Decreased serum ferritin and alopecia in women. J Invest Dermatol 2003; 121: xvii-xviii.

https://doi.org/10.1046/j.1523-1747.2003.12581.x

Kantor J, Kessler LJ, Brooks DG, Cotsarelis G. Decreased serum ferritin is associated with alopecia in women. J Invest Dermatol 2003; 121: 985-988.

https://doi.org/10.1046/j.1523-1747.2003.12540.x

Trost LB, Bergfeld WF, Calogeras E. The diagnosis and treatment of iron deficiency and its potential relationship to hair loss. J Am Acad Dermatol 2006; 54: 824-844.

https://doi.org/10.1016/j.jaad.2005.11.1104

Reynolds RD, Binder HJ, Miller MB, Chang WW, Horan S. Pagophagia and iron deficiency anemia. Ann Intern Med 1968; 69: 435-440.

https://doi.org/10.7326/0003-4819-69-3-435

Ephros HD, Lee HY. Amylophagia and iron deficiency anemia. Oral Surg Oral Med Oral Pathol 1988; 66: 448-449.

https://doi.org/10.1016/0030-4220(88)90265-4

Reimann F, Koptagel G. Geophagia in iron deficiency disease. New Istanbul Contrib Clin Sci 1980; 13: 63-79.

Sharma TR, Kavuru B, Aly M. Coprophagia and pica in individuals with mild to moderate dementia and mixed (iron deficiency and macrocytic) anemia. J Am Geriatr Soc 2011; 59: 2375-2377.

https://doi.org/10.1111/j.1532-5415.2011.03703.x

McGehee FT, Jr., Buchanan GR. Trichophagia and trichobezoar: etiologic role of iron deficiency. J Pediatr 1980; 97: 946-948.

https://doi.org/10.1016/S0022-3476(80)80429-X

Campuzano-Maya G. Pica: el síntoma olvidado. Medicina & Laboratorio 2011; 17: 533-552.

Oski FA. The nonhematologic manifestations of iron deficiency. Am J Dis Child 1979; 133: 315-322.

https://doi.org/10.1001/archpedi.1979.02130030091017

Oski FA, Honig AS, Helu B, Howanitz P. Effect of iron therapy on behavior performance in nonanemic, iron-deficient infants. Pediatrics 1983; 71: 877-880.

Lozoff B, Brittenham GM. Behavioral alterations in iron deficiency. Hematol Oncol Clin North Am 1987; 1: 449-464.

https://doi.org/10.1016/S0889-8588(18)30663-4

Lozoff B. Behavioral alterations in iron deficiency. Adv Pediatr 1988; 35: 331-359.

Lozoff B. Iron deficiency and infant development. J Pediatr 1994; 125: 577-578.

https://doi.org/10.1016/S0022-3476(94)70010-9

Lozoff B, Klein NK, Nelson EC, McClish DK, Manuel M, Chacon ME. Behavior of infants with iron-deficiency anemia. Child Dev 1998; 69: 24-36.

https://doi.org/10.1111/j.1467-8624.1998.tb06130.x

Martinez-Torres C, Cubeddu L, Dillmann E, Brengelmann GL, Leets I, Layrisse M, et al. Effect of exposure to low temperature on normal and iron-deficient subjects. Am J Physiol 1984; 246: R380-383.

https://doi.org/10.1152/ajpregu.1984.246.3.R380

Grantham-McGregor S, Ani C. A review of studies on the effect of iron deficiency on cognitive development in children. J Nutr 2001; 131: 649S-666S; discussion 666S-668S.

https://doi.org/10.1093/jn/131.2.649S

Yager JY, Hartfield DS. Neurologic manifestations of iron deficiency in childhood. Pediatr Neurol 2002; 27: 85-92.

https://doi.org/10.1016/S0887-8994(02)00417-4

Sandoval C. Thrombocytosis in children with iron deficiency anemia: series of 42 children. J Pediatr Hematol Oncol 2002; 24: 593.

https://doi.org/10.1097/00043426-200210000-00025

Fisher NC, Daggett PR. Haemochromatosis presenting with loss of libido and impotence. Eur J Gastroenterol Hepatol 1996; 8: 705-707.

Makila E. Prevalence of angular stomatitis. Correlation with composition of food and metabolism of vitamins and iron. Acta Odontol Scand 1969; 27: 655-680.

https://doi.org/10.3109/00016356909026316

República de Colombia, Comisión de Regulación en Salud (CRES). Por el cual se sustituye el Acuerdo 028 de 2011 que define, aclara y actualiza integralmente el Plan Obligatorio de Salud; 2011.

WHO. WHO. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Vitamin and Mineral Nutrition Information System. Geneva, World Health Organization, 2011 (WHO/NMH/NHD/MNM/11.1) (http://www.who.int/vmnis/indicators/ haemoglobin. pdf, Consultado en junio de 2015.

Campuzano-Maya G. Del hemograma manual al hemograma de cuarta generación. Medicina & Laboratorio 2007; 133: 511-550.

Macdougall IC, Hutton RD, Cavill I, Coles GA, Williams JD. Poor response to treatment of renal anaemia with erythropoietin corrected by iron given intravenously. BMJ 1989; 299: 157-158.

https://doi.org/10.1136/bmj.299.6692.157

Thomas DW, Hinchliffe RF, Briggs C, Macdougall IC, Littlewood T, Cavill I, et al. Guideline for the laboratory diagnosis of functional iron deficiency. Br J Haematol 2013; 161: 639-648.

https://doi.org/10.1111/bjh.12311

Brugnara C. Iron deficiency and erythropoiesis: new diagnostic approaches. Clin Chem 2003; 49: 1573-1578.

https://doi.org/10.1373/49.10.1573

Thomas C, Thomas L. Biochemical markers and hematologic indices in the diagnosis of functional iron deficiency. Clin Chem 2002; 48: 1066-1076.

Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med 2005; 352: 1011-1023.

https://doi.org/10.1056/NEJMra041809

Baillie FJ, Morrison AE, Fergus I. Soluble transferrin receptor: a discriminating assay for iron deficiency. Clin Lab Haematol 2003; 25: 353-357.

https://doi.org/10.1046/j.0141-9854.2003.00548.x

Li YQ, Bai B, Cao XX, Yan H, Zhuang GH. Ferroportin 1 and hephaestin expression in BeWo cell line with different iron treatment. Cell Biochem Funct 2012; 30: 249-255.

https://doi.org/10.1002/cbf.1843

Hudson DM, Krisinger MJ, Griffiths TA, Macgillivray RT. Neither human hephaestin nor ceruloplasmin forms a stable complex with transferrin. J Cell Biochem 2008; 103: 1849-1855.

https://doi.org/10.1002/jcb.21566

Latunde-Dada GO, Van der Westhuizen J, Vulpe CD, Anderson GJ, Simpson RJ, McKie AT. Molecular and functional roles of duodenal cytochrome B (Dcytb) in iron metabolism. Blood Cells Mol Dis 2002; 29: 356-360.

https://doi.org/10.1006/bcmd.2002.0574

McKie AT. The role of Dcytb in iron metabolism: an update. Biochem Soc Trans 2008; 36: 1239-1241.

https://doi.org/10.1042/BST0361239

Lane DJ, Bae DH, Merlot AM, Sahni S, Richardson DR. Duodenal cytochrome b (DCYTB) in iron metabolism: an update on function and regulation. Nutrients 2015; 7: 2274-2296.

https://doi.org/10.3390/nu7042274

Chorney MJ, Yoshida Y, Meyer PN, Yoshida M, Gerhard GS. The enigmatic role of the hemochromatosis protein (HFE) in iron absorption. Trends Mol Med 2003; 9: 118-125.

https://doi.org/10.1016/S1471-4914(03)00023-6

Pantopoulos K. Function of the hemochromatosis protein HFE: Lessons from animal models. World J Gastroenterol 2008; 14: 6893-6901.

https://doi.org/10.3748/wjg.14.6893

Canavesi E, Alfieri C, Pelusi S, Valenti L. Hepcidin and HFE protein: Iron metabolism as a target for the anemia of chronic kidney disease. World J Nephrol 2012; 1: 166-176.

https://doi.org/10.5527/wjn.v1.i6.166

Niederkofler V, Salie R, Arber S. Hemojuvelin is essential for dietary iron sensing, and its mutation leads to severe iron overload. J Clin Invest 2005; 115: 2180-2186.

https://doi.org/10.1172/JCI25683

Young GH, Huang TM, Wu CH, Lai CF, Hou CC, Peng KY, et al. Hemojuvelin modulates iron stress during acute kidney injury: improved by furin inhibitor. Antioxid Redox Signal 2014; 20: 1181-1194.

https://doi.org/10.1089/ars.2013.5366

Shaw GC, Cope JJ, Li L, Corson K, Hersey C, Ackermann GE, et al. Mitoferrin is essential for erythroid iron assimilation. Nature 2006; 440: 96-100.

https://doi.org/10.1038/nature04512

Musci G, Polticelli F, Bonaccorsi di Patti MC. Ceruloplasmin-ferroportin system of iron traffic in vertebrates. World J Biol Chem 2014; 5: 204-215.

Lesjak M, Hoque R, Balesaria S, Skinner V, Debnam ES, Srai SK, et al. Quercetin inhibits intestinal iron absorption and ferroportin transporter expression in vivo and in vitro. PLoS One 2014; 9: e102900.

https://doi.org/10.1371/journal.pone.0102900

Andrews NC. The iron transporter DMT1. Int J Biochem Cell Biol 1999; 31: 991-994.

https://doi.org/10.1016/S1357-2725(99)00065-5

Mims MP, Guan Y, Pospisilova D, Priwitzerova M, Indrak K, Ponka P, et al. Identification of a human mutation of DMT1 in a patient with microcytic anemia and iron overload. Blood 2005; 105: 1337-1342.

https://doi.org/10.1182/blood-2004-07-2966

Przybyszewska J, Zekanowska E. The role of hepcidin, ferroportin, HCP1, and DMT1 protein in iron absorption in the human digestive tract. Prz Gastroenterol 2014; 9: 208-213.

https://doi.org/10.5114/pg.2014.45102

Piva E, Brugnara C, Spolaore F, Plebani M. Clinical utility of reticulocyte parameters. Clin Lab Med 2015; 35: 133-163.

https://doi.org/10.1016/j.cll.2014.10.004

Buttarello M, Temporin V, Ceravolo R, Farina G, Bulian P. The new reticulocyte parameter (RET-Y) of the Sysmex XE 2100: its use in the diagnosis and monitoring of posttreatment sideropenic anemia. Am J Clin Pathol 2004; 121: 489-495.

https://doi.org/10.1309/W65295DTUWK7U1HH

Brugnara C. A hematologic "gold standard" for iron-deficient states? Clin Chem 2002; 48: 981-982.

Bain BJ, Clark DM, Wilkins BS. Special Techniques Applicable to Bone Marrow Diagnosis. En: Bain BJ, Clark DM, Wilkins BS, eds. Bone Marrow Pathology (ed 4ta). Oxford, Reino Unido: Wiley-Blackwell; 2010: 54-99.

https://doi.org/10.1002/9781444309782

Ogilvie C, Fitzsimons K, Fitzsimons EJ. Serum ferritin values in primary care: are high values overlooked? J Clin Pathol 2010; 63: 1124-1126.

https://doi.org/10.1136/jcp.2010.083188

Cook JD. Clinical evaluation of iron deficiency. Semin Hematol 1982; 19: 6-18.

Siimes MA, Addiego JE, Jr., Dallman PR. Ferritin in serum: diagnosis of iron deficiency and iron overload in infants and children. Blood 1974; 43: 581-590.

https://doi.org/10.1182/blood.V43.4.581.581

Cook JD, Lipschitz DA, Miles LE, Finch CA. Serum ferritin as a measure of iron stores in normal subjects. Am J Clin Nutr 1974; 27: 681-687.

https://doi.org/10.1093/ajcn/27.7.681

Lipschitz DA, Cook JD, Finch CA. A clinical evaluation of serum ferritin as an index of iron stores. N Engl J Med 1974; 290: 1213-1216.

https://doi.org/10.1056/NEJM197405302902201

Skikne B, Hershho C. Iron deficiency. En: Anderson GJ, McLaren GD, eds. Iron physiology and pathophysiology in humans. New York, Dordrecht, Heidelberg, London: Humana Press; 2012: 251-282.

https://doi.org/10.1007/978-1-60327-485-2_13

Witte DL. Can serum ferritin be effectively interpreted in the presence of the acute-phase response? Clin Chem 1991; 37: 484-485.

Feelders RA, Vreugdenhil G, Eggermont AM, Kuiper-Kramer PA, van Eijk HG, Swaak AJ. Regulation of iron metabolism in the acute-phase response: interferon gamma and tumour necrosis factor alpha induce hypoferraemia, ferritin production and a decrease in circulating transferrin receptors in cancer patients. Eur J Clin Invest 1998; 28: 520-527.

https://doi.org/10.1046/j.1365-2362.1998.00323.x

Beard JL, Murray-Kolb LE, Rosales FJ, Solomons NW, Angelilli ML. Interpretation of serum ferritin concentrations as indicators of total-body iron stores in survey populations: the role of biomarkers for the acute phase response. Am J Clin Nutr 2006; 84: 1498-1505.

https://doi.org/10.1093/ajcn/84.6.1498

Baharvand M, Manifar S, Akkafan R, Mortazavi H, Sabour S. Serum levels of ferritin, copper, and zinc in patients with oral cancer. Biomed J 2014; 37: 331-336.

https://doi.org/10.4103/2319-4170.132888

Shi HB, Li XD, Jiang JT, Zhao WQ, Ji M, Wu CP. Serum ferritin is elevated in advanced non-small cell lung cancer patients and is associated with efficacy of platinum-based chemotherapy. J Cancer Res Ther 2014; 10: 681-685.

Orlandi R, De Bortoli M, Ciniselli CM, Vaghi E, Caccia D, Garrisi V, et al. Hepcidin and ferritin blood level as noninvasive tools for predicting breast cancer. Ann Oncol 2014; 25: 352-357.

https://doi.org/10.1093/annonc/mdt490

Wang SL, Cao S, Wu R, Chi F, Tang MY, Jin XY, et al. Serum ferritin predicted prognosis in patients with locally advanced pancreatic cancer. Future Oncol 2015; 11: 2905-2910.

https://doi.org/10.2217/fon.15.186

Andrews M, Soto N, Arredondo-Olguin M. Association between ferritin and hepcidin levels and inflammatory status in patients with type 2 diabetes mellitus and obesity. Nutrition 2015; 31: 51-57.

https://doi.org/10.1016/j.nut.2014.04.019

Yeap BB, Divitini ML, Gunton JE, Olynyk JK, Beilby JP, McQuillan B, et al. Higher ferritin levels, but not serum iron or transferrin saturation, are associated with Type 2 diabetes mellitus in adult men and women free of genetic haemochromatosis. Clin Endocrinol (Oxf) 2015; 82: 525-532.

https://doi.org/10.1111/cen.12529

Acton RT, Barton JC, Barton JC. Serum ferritin, insulin resistance, and metabolic syndrome: clinical and laboratory associations in 769 non-hispanic whites without diabetes mellitus in the HEIRS study. Metab Syndr Relat Disord 2015; 13: 57-63.

https://doi.org/10.1089/met.2014.0106

Aregbesola A, Virtanen JK, Voutilainen S, Mursu J, Lagundoye A, Kauhanen J, et al. Serum ferritin and glucose homeostasis: change in the association by glycaemic state. Diabetes Metab Res Rev 2015; 31: 507-514.

https://doi.org/10.1002/dmrr.2628

Momeni A, Behradmanesh MS, Kheiri S, Abasi F. Serum ferritin has correlation with HbA1c in type 2 diabetic patients. Adv Biomed Res 2015; 4: 74.

https://doi.org/10.4103/2277-9175.153900

Abril-Ulloa V, Flores-Mateo G, Sola-Alberich R, Manuel-y-Keenoy B, Arija V. Ferritin levels and risk of metabolic syndrome: meta-analysis of observational studies. BMC Public Health 2014; 14: 483.

https://doi.org/10.1186/1471-2458-14-483

Padwal MK, Murshid M, Nirmale P, Melinkeri RR. Association of serum ferritin levels with metabolic syndrome and insulin resistance. J Clin Diagn Res 2015; 9: BC11-13.

https://doi.org/10.7860/JCDR/2015/13480.6564

Jin Y, He L, Chen Y, Fang Y, Yao Y. Association between serum ferritin levels and metabolic syndrome: an updated meta-analysis. Int J Clin Exp Med 2015; 8: 13317-13322.

Sumida Y, Kanemasa K, Fukumoto K, Yoshida N, Sakai K. Correlation of hepatic steatosis with body mass index, serum ferritin level and hepatic fibrosis in Japanese patients with chronic hepatitis C. Hepatol Res 2007; 37: 263-269.

https://doi.org/10.1111/j.1872-034X.2007.00038.x

Won JE, Jeong SH, Chung JI, Lee JH, Hwang SH, Kim JW, et al. Hepatic iron, serum ferritin, HFE mutation, and hepatic fibrosis in chronic hepatitis C. Intervirology 2009; 52: 239-246.

https://doi.org/10.1159/000228547

Naz N, Moriconi F, Ahmad S, Amanzada A, Khan S, Mihm S, et al. Ferritin L is the sole serum ferritin constituent and a positive hepatic acute-phase protein. Shock 2013; 39: 520-526.

https://doi.org/10.1097/SHK.0b013e31829266b9

Chick J, Pikkarainen J, Plant M. Serum ferritin as a marker of alcohol consumption in working men. Alcohol Alcohol 1987; 22: 75-77.

Milman N, Kirchhoff M. Relationship between serum ferritin, alcohol intake, and social status in 2235 Danish men and women. Ann Hematol 1996; 72: 145-151.

https://doi.org/10.1007/s002770050153

Fletcher LM, Halliday JW, Powell LW. Interrelationships of alcohol and iron in liver disease with particular reference to the iron-binding proteins, ferritin and transferrin. J Gastroenterol Hepatol 1999; 14: 202-214.

https://doi.org/10.1046/j.1440-1746.1999.01836.x

Kopelman RC, Smith L, Peoples L, Biesecker R, Rizkala AR. Functional iron deficiency in hemodialysis patients with high ferritin. Hemodial Int 2007; 11: 238-246.

https://doi.org/10.1111/j.1542-4758.2007.00175.x

Kuragano T, Matsumura O, Matsuda A, Hara T, Kiyomoto H, Murata T, et al. Association between hemoglobin variability, serum ferritin levels, and adverse events/mortality in maintenance hemodialysis patients. Kidney Int 2014.

https://doi.org/10.1038/ki.2014.114

Takasawa K, Takaeda C, Maeda T, Ueda N. Hepcidin-25, mean corpuscular volume, and ferritin as predictors of response to oral iron supplementation in hemodialysis patients. Nutrients 2015; 7: 103-118.

https://doi.org/10.3390/nu7010103

Lien CT, Lin KC, Tsai YF, Yu LK, Huang LH, Chen CA. Serum ferritin is associated with progression of peripheral arterial disease in hemodialysis patients. Clin Exp Nephrol 2015; 19: 947-952.

https://doi.org/10.1007/s10157-014-1074-y

Beciragic A, Resic H, Prohic N, Karamehic J, Smajlovic A, Masnic F, et al. Correlation Between C-reactive Protein and Non-enzymatic Antioxidants (Albumin, Ferritin, Uric Acid and Bilirubin) in Hemodialysis Patients. Mater Sociomed 2015; 27: 87-90.

https://doi.org/10.5455/msm.2015.27.87-90

Dale JC, Burritt MF, Zinsmeister AR. Diurnal variation of serum iron, iron-binding capacity, transferrin saturation, and ferritin levels. Am J Clin Pathol 2002; 117: 802-808.

https://doi.org/10.1309/2YT4-CMP3-KYW7-9RK1

Weinstein DA, Roy CN, Fleming MD, Loda MF, Wolfsdorf JI, Andrews NC. Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease. Blood 2002; 100: 3776-3781.

https://doi.org/10.1182/blood-2002-04-1260

Nemeth E, Valore EV, Territo M, Schiller G, Lichtenstein A, Ganz T. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 2003; 101: 2461-2463.

https://doi.org/10.1182/blood-2002-10-3235

Detivaud L, Nemeth E, Boudjema K, Turlin B, Troadec MB, Leroyer P, et al. Hepcidin levels in humans are correlated with hepatic iron stores, hemoglobin levels, and hepatic function. Blood 2005; 106: 746-748.

https://doi.org/10.1182/blood-2004-12-4855

Kemna E, Tjalsma H, Laarakkers C, Nemeth E, Willems H, Swinkels D. Novel urine hepcidin assay by mass spectrometry. Blood 2005; 106: 3268-3270.

https://doi.org/10.1182/blood-2005-05-1873

Pak M, Lopez MA, Gabayan V, Ganz T, Rivera S. Suppression of hepcidin during anemia requires erythropoietic activity. Blood 2006; 108: 3730-3735.

https://doi.org/10.1182/blood-2006-06-028787

Miwa N, Akiba T, Kimata N, Hamaguchi Y, Arakawa Y, Tamura T, et al. Usefulness of measuring reticulocyte hemoglobin equivalent in the management of haemodialysis patients with iron deficiency. Int J Lab Hematol 2010; 32: 248-255.

https://doi.org/10.1111/j.1751-553X.2009.01179.x

Brugnara C, Schiller B, Moran J. Reticulocyte hemoglobin equivalent (Ret He) and assessment of iron-deficient states. Clin Lab Haematol 2006; 28: 303-308.

https://doi.org/10.1111/j.1365-2257.2006.00812.x

Feelders RA, Kuiper-Kramer EP, van Eijk HG. Structure, function and clinical significance of transferrin receptors. Clin Chem Lab Med 1999; 37: 1-10.

https://doi.org/10.1515/CCLM.1999.001

Trinder D, Baker E. Transferrin receptor 2: a new molecule in iron metabolism. Int J Biochem Cell Biol 2003; 35: 292-296.

https://doi.org/10.1016/S1357-2725(02)00258-3

Pettersson T, Kivivuori SM, Siimes MA. Is serum transferrin receptor useful for detecting iron-deficiency in anaemic patients with chronic inflammatory diseases? Br J Rheumatol 1994; 33: 740-744.

https://doi.org/10.1093/rheumatology/33.8.740

Skikne BS. Circulating transferrin receptor assay--coming of age. Clin Chem 1998; 44: 7-9.

Verhoef H, West CE, Ndeto P, Burema J, Beguin Y, Kok FJ. Serum transferrin receptor concentration indicates increased erythropoiesis in Kenyan children with asymptomatic malaria. Am J Clin Nutr 2001; 74: 767-775.

https://doi.org/10.1093/ajcn/74.6.767

Menendez C, Quinto LL, Kahigwa E, Alvarez L, Fernandez R, Gimenez N, et al. Effect of malaria on soluble transferrin receptor levels in Tanzanian infants. Am J Trop Med Hyg 2001; 65: 138-142.

https://doi.org/10.4269/ajtmh.2001.65.138

Vitamin and Mineral Nutrition Information System. Serum transferrin receptor levels for the assessment of iron status and iron deficiency in populations. Ginebra, Suiza: Organización Mundial de la Salud. 2014. Disponible: http://apps.who.int/iris/bitstream/10665/133707/1/WHO_NMH_NHD_EPG_14.6_eng.pdf. Consultado: feb 2015.

Krause A, Neitz S, Magert HJ, Schulz A, Forssmann WG, Schulz-Knappe P, et al. LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett 2000; 480: 147-150.

https://doi.org/10.1016/S0014-5793(00)01920-7

Pigeon C, Ilyin G, Courselaud B, Leroyer P, Turlin B, Brissot P, et al. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 2001; 276: 7811-7819.

https://doi.org/10.1074/jbc.M008923200

Park CH, Valore EV, Waring AJ, Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 2001; 276: 7806-7810.

https://doi.org/10.1074/jbc.M008922200

Sow FB, Nandakumar S, Velu V, Kellar KL, Schlesinger LS, Amara RR, et al. Mycobacterium tuberculosis components stimulate production of the antimicrobial peptide hepcidin. Tuberculosis (Edinb) 2011; 91: 314-321.

https://doi.org/10.1016/j.tube.2011.03.003

Atanasiu V, Manolescu B, Stoian I. Hepcidin--central regulator of iron metabolism. Eur J Haematol 2007; 78: 1-10.

https://doi.org/10.1111/j.1600-0609.2006.00772.x

Hugman A. Hepcidin: an important new regulator of iron homeostasis. Clin Lab Haematol 2006; 28: 75-83.

https://doi.org/10.1111/j.1365-2257.2006.00768.x

Ganz T, Nemeth E. Hepcidin and iron homeostasis. Biochim Biophys Acta 2012; 1823: 1434-1443.

https://doi.org/10.1016/j.bbamcr.2012.01.014

Ganz T, Olbina G, Girelli D, Nemeth E, Westerman M. Immunoassay for human serum hepcidin. Blood 2008; 112: 4292-4297.

https://doi.org/10.1182/blood-2008-02-139915

Kroot JJ, Kemna EH, Bansal SS, Busbridge M, Campostrini N, Girelli D, et al. Results of the first international round robin for the quantification of urinary and plasma hepcidin assays: need for standardization. Haematologica 2009; 94: 1748-1752.

https://doi.org/10.3324/haematol.2009.010322

Wintrobe MM. Anemia: Classification and treatment on the basis of differences in the average volume and hemoglobin content of the red corpuscles. Arch Intern Med 1934; 54: 256-261.

https://doi.org/10.1001/archinte.1934.00160140099006

Bessman JD, Gilmer PR, Jr., Gardner FH. Improved classification of anemias by MCV and RDW. Am J Clin Pathol 1983; 80: 322-326.

https://doi.org/10.1093/ajcp/80.3.322

Bessman D. What's an RDW? Am J Clin Pathol 1981; 76: 242-243.

https://doi.org/10.1093/ajcp/76.2.242a

Bessman JD, Johnson RK. Erythrocyte volume distribution in normal and abnormal subjects. Blood 1975; 46: 369-379.

https://doi.org/10.1182/blood.V46.3.369.369

Torino AB, Gilberti Mde F, da Costa E, de Lima GA, Grotto HZ. Evaluation of red cell and reticulocyte parameters as indicative of iron deficiency in patients with anemia of chronic disease. Rev Bras Hematol Hemoter 2014; 36: 424-429.

https://doi.org/10.1016/j.bjhh.2014.09.004

Mohandas N, Kim YR, Tycko DH, Orlik J, Wyatt J, Groner W. Accurate and independent measurement of volume and hemoglobin concentration of individual red cells by laser light scattering. Blood 1986; 68: 506-513.

https://doi.org/10.1182/blood.V68.2.506.506

Garzia M, Di Mario A, Ferraro E, Tazza L, Rossi E, Luciani G, et al. Reticulocyte Hemoglobin Equivalent: An Indicator of Reduced Iron Availability in Chronic Kidney Diseases during Erythropoietin Therapy. Lab Hematol 2007; 13: 6-11.

https://doi.org/10.1532/LH96.06037

Nunes LA, Grotto HZ, Brenzikofer R, Macedo DV. Hematological and biochemical markers of iron status in a male, young, physically active population. Biomed Res Int 2014; 2014: 349182.

https://doi.org/10.1155/2014/349182

Canals C, Remacha AF, Sarda MP, Piazuelo JM, Royo MT, Romero MA. Clinical utility of the new Sysmex XE 2100 parameter - reticulocyte hemoglobin equivalent - in the diagnosis of anemia. Haematologica 2005; 90: 1133-1134.

Kickler TS, Borowitz MJ, Thompson RE, Charintranont N, Law R. Ret-Y a measure of reticulocyte size: a sensitive indicator of iron deficiency anemia. Clin Lab Haematol 2004; 26: 423-427.

https://doi.org/10.1111/j.1365-2257.2004.00645.x

Franck S, Linssen J, Messinger M, Thomas L. Potential utility of Ret-Y in the diagnosis of iron-restricted erythropoiesis. Clin Chem 2004; 50: 1240-1242.

https://doi.org/10.1373/clinchem.2004.030254

Markovic M, Majkic-Singh N, Subota V, Mijuskovic Z. Reticulocyte hemoglobin content in the diagnosis of iron deficiency anemia. Clin Lab 2004; 50: 431-436.

Thomas L, Franck S, Messinger M, Linssen J, Thome M, Thomas C. Reticulocyte hemoglobin measurement--comparison of two methods in the diagnosis of iron-restricted erythropoiesis. Clin Chem Lab Med 2005; 43: 1193-1202.

https://doi.org/10.1515/CCLM.2005.207

Ullrich C, Wu A, Armsby C, Rieber S, Wingerter S, Brugnara C, et al. Screening healthy infants for iron deficiency using reticulocyte hemoglobin content. JAMA 2005; 294: 924-930.

https://doi.org/10.1001/jama.294.8.924

Mast AE, Blinder MA, Dietzen DJ. Reticulocyte hemoglobin content. Am J Hematol 2008; 83: 307-310.

https://doi.org/10.1002/ajh.21090

Karagulle M, Gunduz E, Sahin Mutlu F, Olga Akay M. Clinical significance of reticulocyte hemoglobin content in the diagnosis of iron deficiency anemia. Turk J Haematol 2013; 30: 153-156.

https://doi.org/10.4274/Tjh.2012.0107

Brugnara C, Zurakowski D, DiCanzio J, Boyd T, Platt O. Reticulocyte hemoglobin content to diagnose iron deficiency in children. Jama 1999; 281: 2225-2230.

https://doi.org/10.1001/jama.281.23.2225

Bakr AF, Sarette G. Measurement of reticulocyte hemoglobin content to diagnose iron deficiency in Saudi children. Eur J Pediatr 2006; 165: 442-445.

https://doi.org/10.1007/s00431-006-0097-0

Kiudeliene R, Griniute R, Labanauskas L. Prognostic value of reticulocyte hemoglobin content to diagnose iron deficiency in 6-24-month-old children. Medicina (Kaunas) 2008; 44: 673-677.

https://doi.org/10.3390/medicina44090086

Mateos ME, De-la-Cruz J, Lopez-Laso E, Valdes MD, Nogales A. Reticulocyte hemoglobin content for the diagnosis of iron deficiency. J Pediatr Hematol Oncol 2008; 30: 539-542.

https://doi.org/10.1097/MPH.0b013e31817580ca

Kuehn D, Roberts SS, Olsen CH, Harvey DN, Charnock KM, Brewer BD, et al. Reticulocyte hemoglobin content testing for iron deficiency in healthy toddlers. Mil Med 2012; 177: 91-95.

https://doi.org/10.7205/MILMED-D-11-00243

Osta V, Caldirola MS, Fernandez M, Marcone MI, Tissera G, Pennesi S, et al. Utility of new mature erythrocyte and reticulocyte indices in screening for iron-deficiency anemia in a pediatric population. Int J Lab Hematol 2013; 35: 400-405.

https://doi.org/10.1111/ijlh.12030

Al-Ghananim RT, Nalbant D, Schmidt RL, Cress GA, Zimmerman MB, Widness JA. Reticulocyte Hemoglobin Content During the First Month of Life in Critically Ill Very Low Birth Weight Neonates Differs From Term Infants, Children, and Adults. J Clin Lab Anal 2015.

https://doi.org/10.1002/jcla.21859

Stoffman N, Brugnara C, Woods ER. An algorithm using reticulocyte hemoglobin content (CHr) measurement in screening adolescents for iron deficiency. J Adolesc Health 2005; 36: 529.

https://doi.org/10.1016/j.jadohealth.2004.09.011

Schoorl M, Schoorl M, van der Gaag D, Bartels PC. Effects of iron supplementation on red blood cell hemoglobin content in pregnancy. Hematol Rep 2012; 4: e24.

https://doi.org/10.4081/hr.2012.e24

Ageeli AA, Algahtani FH, Alsaeed AH. Reticulocyte hemoglobin content and iron deficiency: a retrospective study in adults. Genet Test Mol Biomarkers 2013; 17: 278-283.

https://doi.org/10.1089/gtmb.2012.0337

Luo D, Chen Y, Wu W, Zhang F, Xu J, Cui W, et al. Reticulocyte hemoglobin content in the diagnosis of iron deficiency in Chinese pre-menopausal women. Chin Med J (Engl) 2007; 120: 1010-1012.

https://doi.org/10.1097/00029330-200706010-00013

Karlsson T. Comparative evaluation of the reticulocyte hemoglobin content assay when screening for iron deficiency in elderly anemic patients. Anemia 2011; 2011: 925907.

https://doi.org/10.1155/2011/925907

Joosten E, Lioen P, Brusselmans C, Indevuyst C, Boeckx N. Is analysis of the reticulocyte haemoglobin equivalent a useful test for the diagnosis of iron deficiency anaemia in geriatric patients? Eur J Intern Med 2013; 24: 63-66.

https://doi.org/10.1016/j.ejim.2012.09.001

Bhandari S, Norfolk D, Brownjohn A, Turney J. Evaluation of RBC ferritin and reticulocyte measurements in monitoring response to intravenous iron therapy. Am J Kidney Dis 1997; 30: 814-821.

https://doi.org/10.1016/S0272-6386(97)90087-1

Brugnara C, Colella GM, Cremins J, Langley RC, Jr., Schneider TJ, Rutherford CJ, et al. Effects of subcutaneous recombinant human erythropoietin in normal subjects: development of decreased reticulocyte hemoglobin content and iron-deficient erythropoiesis. J Lab Clin Med 1994; 123: 660-667.

Brugnara C. Reticulocyte cellular indices: a new approach in the diagnosis of anemias and monitoring of erythropoietic function. Crit Rev Clin Lab Sci 2000; 37: 93-130.

https://doi.org/10.1080/10408360091174196

Mittman N, Sreedhara R, Mushnick R, Chattopadhyay J, Zelmanovic D, Vaseghi M, et al. Reticulocyte hemoglobin content predicts functional iron deficiency in hemodialysis patients receiving rHuEPO. Am J Kidney Dis 1997; 30: 912-922.

https://doi.org/10.1016/S0272-6386(97)90104-9

Semmelrock MJ, Raggam RB, Amrein K, Avian A, Schallmoser K, Lanzer G, et al. Reticulocyte hemoglobin content allows early and reliable detection of functional iron deficiency in blood donors. Clin Chim Acta 2012; 413: 678-682.

https://doi.org/10.1016/j.cca.2011.12.006

Markovic M, Majkic-Singh N, Ignjatovic S, Singh S. Reticulocyte haemoglobin content vs. soluble transferrin receptor and ferritin index in iron deficiency anaemia accompanied with inflammation. Int J Lab Hematol 2007; 29: 341-346.

https://doi.org/10.1111/j.1365-2257.2006.00875.x

Jolobe O. Reticulocyte haemoglobin content vs. soluble transferrin receptor and ferritin index in iron deficiency anaemia accompanied with inflammation. Int J Lab Hematol 2008; 30: 175-176.

https://doi.org/10.1111/j.1751-553X.2008.01035.x

Jayaranee S, Sthaneshwar P. RET-Y and RBC-Y in the diagnosis of iron deficiency associated with anaemia of inflammation. Int J Lab Hematol 2010; 32: 512-518.

https://doi.org/10.1111/j.1751-553X.2009.01215.x

Darveau M, Lachance P. Reticulocyte hemoglobin content in critically ill patients. Anesthesiology 2010; 113: 1479.

https://doi.org/10.1097/ALN.0b013e3181f85eee

Schoorl M, Snijders D, Schoorl M, Boersma WG, Bartels PC. Transient impairment of reticulocyte hemoglobin content and hepcidin-25 induction in patients with community-acquired pneumonia. Scand J Clin Lab Invest 2013; 73: 54-60.

https://doi.org/10.3109/00365513.2012.735694

Thomas C, Thomas L. Anemia of chronic disease: pathophysiology and laboratory diagnosis. Lab Hematol 2005; 11: 14-23.

https://doi.org/10.1532/LH96.04049

Peerschke EI, Pessin MS, Maslak P. Using the hemoglobin content of reticulocytes (RET-He) to evaluate anemia in patients with cancer. Am J Clin Pathol 2014; 142: 506-512.

https://doi.org/10.1309/AJCPCVZ5B0BOYJGN

Cullen P, Soffker J, Hopfl M, Bremer C, Schlaghecken R, Mehrens T, et al. Hypochromic red cells and reticulocyte haemglobin content as markers of iron-deficient erythropoiesis in patients undergoing chronic haemodialysis. Nephrol Dial Transplant 1999; 14: 659-665.

https://doi.org/10.1093/ndt/14.3.659

Fishbane S, Galgano C, Langley RC, Jr., Canfield W, Maesaka JK. Reticulocyte hemoglobin content in the evaluation of iron status of hemodialysis patients. Kidney Int 1997; 52: 217-222.

https://doi.org/10.1038/ki.1997.323

Bhandari S, Turney JH, Brownjohn AM, Norfolk D. Reticulocyte indices in patients with end stage renal disease on hemodialysis. J Nephrol 1998; 11: 78-82.

Bhandari S, Brownjohn AM, Turney JH. Response of mean reticulocyte haemoglobin content to intravenous iron therapy in haemodialysis patients. Nephrol Dial Transplant 1998; 13: 3276-3277.

https://doi.org/10.1093/ndt/13.12.3276

Chuang CL, Liu RS, Wei YH, Huang TP, Tarng DC. Early prediction of response to intravenous iron supplementation by reticulocyte haemoglobin content and high-fluorescence reticulocyte count in haemodialysis patients. Nephrol Dial Transplant 2003; 18: 370-377.

https://doi.org/10.1093/ndt/18.2.370

Mitsuiki K, Harada A, Miyata Y. Assessment of iron deficiency in chronic hemodialysis patients: investigation of cutoff values for reticulocyte hemoglobin content. Clin Exp Nephrol 2003; 7: 52-57.

https://doi.org/10.1007/s101570300007

Hackeng CM, Beerenhout CM, Hermans M, Van der Kuy PH, Van der Dussen H, Van Dieijen-Visser MP, et al. The relationship between reticulocyte hemoglobin content with C-reactive protein and conventional iron parameters in dialysis patients. J Nephrol 2004; 17: 107-111.

Mitsuiki K, Harada A, Miyata Y. Reticulocyte hemoglobin content in hemodialysis patients with acute infection. Clin Exp Nephrol 2004; 8: 257-262.

https://doi.org/10.1007/s10157-004-0295-x

Tsuchiya K, Saito M, Okano-Sugiyama H, Nihei H, Ando M, Teramura M, et al. Monitoring the content of reticulocyte hemoglobin (CHr) as the progression of anemia in nondialysis chronic renal failure (CRF) patients. Ren Fail 2005; 27: 59-65.

https://doi.org/10.1081/JDI-42792

Fusaro M, Munaretto G, Spinello M, Rebeschini M, Amici G, Gallieni M, et al. Soluble transferrin receptors and reticulocyte hemoglobin concentration in the assessment of iron deficiency in hemodialysis patients. J Nephrol 2005; 18: 72-79.

David O, Grillo A, Ceoloni B, Cavallo F, Podda G, Biancotti PP, et al. Analysis of red cell parameters on the Sysmex XE 2100 and ADVIA 120 in iron deficiency and in uraemic chronic disease. Scand J Clin Lab Invest 2006; 66: 113-120.

https://doi.org/10.1080/00365510500406910

El-Khatib M, Duncan HJ, Kant KS. Role of C-reactive protein, reticulocyte haemoglobin content and inflammatory markers in iron and erythropoietin administration in dialysis patients. Nephrology (Carlton) 2006; 11: 400-404.

https://doi.org/10.1111/j.1440-1797.2006.00676.x

Schoorl M, Schoorl M, Nube MJ, Bartels PC. Erythropoiesis activity, iron availability and reticulocyte hemoglobinization during treatment with hemodialysis and in subjects with uremia. Clin Lab 2006; 52: 621-629.

Kim JM, Ihm CH, Kim HJ. Evaluation of reticulocyte haemoglobin content as marker of iron deficiency and predictor of response to intravenous iron in haemodialysis patients. Int J Lab Hematol 2008; 30: 46-52.

Ng HY, Chen HC, Pan LL, Tsai YC, Hsu KT, Liao SC, et al. Clinical interpretation of reticulocyte hemoglobin content, RET-Y, in chronic hemodialysis patients. Nephron Clin Pract 2009; 111: c247-252.

https://doi.org/10.1159/000209151

Buttarello M, Pajola R, Novello E, Rebeschini M, Cantaro S, Oliosi F, et al. Diagnosis of iron deficiency in patients undergoing hemodialysis. Am J Clin Pathol 2010; 133: 949-954.

https://doi.org/10.1309/AJCPQAX0JFHFS0OA

Eguchi A, Mochizuki T, Tsukada M, Kataoka K, Hamaguchi Y, Oguni S, et al. Serum hepcidin levels and reticulocyte hemoglobin concentrations as indicators of the iron status of peritoneal dialysis patients. Int J Nephrol 2012; 2012: 239476.

https://doi.org/10.1155/2012/239476

Forni V, Bianchi G, Ogna A, Salvade I, Vuistiner P, Burnier M, et al. Reticulocyte dynamic and hemoglobin variability in hemodialysis patients treated with Darbepoetin alfa and C.E.R.A.: a randomized controlled trial. BMC Nephrol 2013; 14: 157.

https://doi.org/10.1186/1471-2369-14-157

Kakimoto-Shino M, Toya Y, Kuji T, Fujikawa T, Umemura S. Changes in Hepcidin and Reticulocyte Hemoglobin Equivalent Levels in Response to Continuous Erythropoietin Receptor Activator Administration in Hemodialysis Patients: A Randomized Study. Ther Apher Dial 2014.

https://doi.org/10.1111/1744-9987.12161

Kuji T, Toya Y, Fujikawa T, Kakimoto-Shino M, Nishihara M, Shibata K, et al. Acceleration of Iron Utilization After Intravenous Iron Administration During Activated Erythropoiesis in Hemodialysis Patients: A Randomized Study. Ther Apher Dial 2014.

https://doi.org/10.1111/1744-9987.12237

National Kidney Foundation. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease. Am J Kidney Dis 2006; 47: S1-S146.

https://doi.org/10.1053/j.ajkd.2006.03.011

Fishbane S, Shapiro W, Dutka P, Valenzuela OF, Faubert J. A randomized trial of iron deficiency testing strategies in hemodialysis patients. Kidney Int 2001; 60: 2406-2411.

https://doi.org/10.1046/j.1523-1755.2001.00077.x

Brugnara C, Laufer MR, Friedman AJ, Bridges K, Platt O. Reticulocyte hemoglobin content (CHr): early indicator of iron deficiency and response to therapy. Blood 1994; 83: 3100-3101.

https://doi.org/10.1182/blood.V83.10.3100.3100

Skarmoutsou C, Papassotiriou I, Traeger-Synodinos J, Stamou H, Ladis V, Metaxotou-Mavrommati A, et al. Erythroid bone marrow activity and red cell hemoglobinization in iron sufficient beta-thalassemia heterozygotes as reflected by soluble transferrin receptor and reticulocyte hemoglobin in content. Correlation with genotypes and Hb A(2) levels. Haematologica 2003; 88: 631-636.

Sudmann AA, Piehler A, Urdal P. Reticulocyte hemoglobin equivalent to detect thalassemia and thalassemic hemoglobin variants. Int J Lab Hematol 2012.

https://doi.org/10.1111/j.1751-553X.2012.01442.x

Bridges KR, Barabino GD, Brugnara C, Cho MR, Christoph GW, Dover G, et al. A multiparameter analysis of sickle erythrocytes in patients undergoing hydroxyurea therapy. Blood 1996; 88: 4701-4710.

https://doi.org/10.1182/blood.V88.12.4701.bloodjournal88124701

Mast AE, Blinder MA, Lu Q, Flax S, Dietzen DJ. Clinical utility of the reticulocyte hemoglobin content in the diagnosis of iron deficiency. Blood 2002; 99: 1489-1491.

https://doi.org/10.1182/blood.V99.4.1489

Cómo citar
1.
Campuzano-Maya G, Guevara-Arismendy NM. Hemoglobina reticulocitaria: un nuevo parámetro del hemograma de gran valor en el diagnóstico y manejo de la eritropoyesis deficiente en hierro. Med. Lab. [Internet]. 1 de enero de 2015 [citado 8 de diciembre de 2021];21(1-2):11-2. Disponible en: https://medicinaylaboratorio.com/index.php/myl/article/view/107
Publicado
2015-01-01
Sección
La Clínica y el Laboratorio
Crossref Cited-by logo

Artículos más leídos del mismo autor/a

1 2 > >>